子宫动脉栓塞术治疗抗凝相关异常子宫出血的疗效
回顾性病例系列纳入24例抗凝治疗诱发或加重的异常子宫出血患者,接受子宫动脉栓塞术(UAE)而非下腔静脉滤器置入和子宫切除术。结果显示88%患者出血显著改善或消失并继续抗凝治疗,14%无改善行子宫切除术,1例45岁患者术后即刻闭经。UAE在该队列中有效,允许继续抗凝并高比例保留子宫和月经。
要点
- UAE可使88%抗凝相关异常子宫出血患者出血改善并继续抗凝治疗。
- 14%患者UAE后无改善,需行子宫切除术。
- 1例45岁患者UAE后即刻出现闭经,多数患者保留月经。
核心结论
- UAE在该队列中是抗凝相关异常子宫出血的有效处理工具,可减少出血并允许继续抗凝治疗,子宫保留率和月经保留率高。
研究设计与样本
- 回顾性病例系列,纳入24例抗凝治疗诱发或加重的异常子宫出血患者,年龄35至54岁(平均44.9岁)。
主要发现
- 静脉血栓栓塞性疾病是最常见的抗凝指征(92%)。
- 就诊时14例(58%)预计需终身抗凝。
- 多数UAE手术(54%)在开始抗凝后10天内进行。
- UAE前17例(71%)尝试并失败于药物管理、子宫肌瘤剔除术或子宫内膜消融术。
- UAE后21例(88%)出血显著改善或消失并继续抗凝治疗,3例(14%)无改善行子宫切除术。
临床怎么用
- 对于抗凝相关异常子宫出血且药物管理失败或急性出血的患者,可考虑UAE作为替代下腔静脉滤器置入和子宫切除术的选择,以继续抗凝并保留子宫。
局限性
- 回顾性病例系列,样本量小(24例),来自单中心学术医院,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: Data regarding uterine artery embolization (UAE) to specifically treat anticoagulant-associated iatrogenic abnormal uterine bleeding (AUB-I) are sparse. This manuscript aimed to quantify the effectiveness of UAE in treating this subset of patients. DESIGN: Retrospective case series. SETTING: Academic hospital serving a large minority-majority population. PATIENTS: Twenty-four patients with AUB-I that was provoked or aggravated by the initiation of anticoagulation therapy. INTERVENTIONS: Treatment of anticoagulant-associated AUB-I that failed medical management or was acute with UAE rather than inferior vena cava filter placement and hysterectomy. MEASUREMENTS AND MAIN RESULTS: An imaging database search was performed to identify patients who underwent UAE for anticoagulant-associated AUB-I from May 2011 to July 2020. Medical and radiologic records were reviewed. Short- and long-term outcomes were obtained to date, ranging from 10 months to 10 years after the procedure. In total, 24 patients were identified, ranging in age from 35 to 54 (mean 44.9) years. Venous thromboembolic disease was the most common (92%) indication for anticoagulation. At presentation, 14 patients (58%) were anticipated to require lifelong anticoagulation. Most UAE procedures (54%) occurred within 10 days of anticoagulation initiation. Before UAE, 17 patients (71%) attempted and failed medical management, myomectomy, or endometrial ablation to control bleeding. After UAE, 21 patients (88%) experienced substantial improvement or resolution of AUB and continued anticoagulation therapy. Three patients (14%) did not experience improvement and were treated with hysterectomy. Amenorrhea immediately after UAE occurred in 1 patient at age 45. CONCLUSION: UAE was an effective tool in the management of anticoagulant associated AUB-I in this cohort, resulting in decreased bleeding while allowing the continuation of anticoagulation therapy, with high rates of uterine preservation and preserved menses.
引用
- Wattamwar K, Arabkhazaeli M, Shin J, et al. Efficacy of Uterine Artery Embolization for Treatment of Anticoagulant-Associated Abnormal Uterine Bleeding. J Minim Invasive Gynecol. 2021. PMID: 34280566. doi:10.1016/j.jmig.2021.07.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。